Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

NCT04309136 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: Anlotinib
PROCEDURE: surgery
PROCEDURE: core needle biopsy

Sponsor

Fudan University